Three-Dimensional In Vitro Co-Culture Model of Breast Tumor using Magnetic Levitation

In this study, we investigate a novel in vitro model to mimic heterogeneous breast tumors without the use of a scaffold while allowing for cell-cell and tumor-fibroblast interactions. Previous studies have shown that magnetic levitation system under conventional culturing conditions results in the formation of three-dimensional (3D) structures, closely resembling in vivo tissues (fat tissue, vasculature, etc.). Three-dimensional heterogeneous tumor models for breast cancer were designed to effectively model the influences of the tumor microenvironment on drug efficiency. Various breast cancer cells were co-cultured with fibroblasts and then magnetically levitated. Size and cell density of the resulting tumors were measured. The model was phenotypically compared to in vivo tumors and examined for the presence of ECM proteins. Lastly, the effects of tumor stroma in the 3D in vitro model on drug transport and efficiency were assessed. Our data suggest that the proposed 3D in vitro breast tumor is advantageous due to the ability to: (1) form large-sized (millimeter in diameter) breast tumor models within 24 h; (2) control tumor cell composition and density; (3) accurately mimic the in vivo tumor microenvironment; and (4) test drug efficiency in an in vitro model that is comparable to in vivo tumors.

[1]  William L. Haisler,et al.  Three-dimensional cell culturing by magnetic levitation , 2013, Nature Protocols.

[2]  Marian Kelley,et al.  One size does not fit all. , 2011, Bioanalysis.

[3]  J Kulka,et al.  The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer , 2014, British Journal of Cancer.

[4]  J. Brugge,et al.  Use of Three-Dimensional Basement Membrane Cultures to Model Oncogene-Induced Changes in Mammary Epithelial Morphogenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.

[5]  Maria Vinci,et al.  Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation , 2012, BMC Biology.

[6]  Kevin P. Rosenblatt,et al.  A high-throughput three-dimensional cell migration assay for toxicity screening with mobile device-based macroscopic image analysis , 2013, Scientific Reports.

[7]  Kenneth M. Yamada,et al.  Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.

[8]  Bo Ri Seo,et al.  In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. , 2014, Advanced drug delivery reviews.

[9]  Stephen T. C. Wong,et al.  Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling , 2014, Proceedings of the National Academy of Sciences.

[10]  Joseph W Freeman,et al.  3D in vitro bioengineered tumors based on collagen I hydrogels. , 2011, Biomaterials.

[11]  Anne-Marie Mes-Masson,et al.  Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC) , 2007, Molecular carcinogenesis.

[12]  M. Alpaugh,et al.  Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis , 2009, BMC Cancer.

[13]  Genee Y. Lee,et al.  Three-dimensional culture models of normal and malignant breast epithelial cells , 2007, Nature Methods.

[14]  Houqiang Liu,et al.  Tumor-Stroma Ratio Is an Independent Predictor for Survival in Esophageal Squamous Cell Carcinoma , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  D. Hutmacher,et al.  Engineered silk fibroin protein 3D matrices for in vitro tumor model. , 2011, Biomaterials.

[16]  J. Rosen,et al.  Modelling breast cancer: one size does not fit all , 2007, Nature Reviews Cancer.

[17]  Sara I. Montanez-Sauri,et al.  Enabling screening in 3D microenvironments: probing matrix and stromal effects on the morphology and proliferation of T47D breast carcinoma cells. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[18]  C. Tung,et al.  Detection of hydroxyapatite in calcified cardiovascular tissues. , 2012, Atherosclerosis.

[19]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[20]  M. O'hare,et al.  Three-dimensional in vitro tissue culture models of breast cancer — a review , 2004, Breast Cancer Research and Treatment.

[21]  Sara I. Montanez-Sauri,et al.  Enabling screening in 3 D microenvironments : probing matrix and stromal effects on the morphology and proliferation of T 47 D breast carcinoma cells † , 2013 .

[22]  M. Kolonin,et al.  Adipose tissue engineering in three-dimensional levitation tissue culture system based on magnetic nanoparticles. , 2013, Tissue engineering. Part C, Methods.

[23]  Yu Shyr,et al.  RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells , 2010, Breast Cancer Research.

[24]  W. E. Mesker,et al.  Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854) , 2013, Breast Cancer Research and Treatment.

[25]  Christopher S. Stevenson,et al.  In Vivo Models of Inflammation , 1999, Progress in Inflammation Research.

[26]  I. Tannock,et al.  Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib , 2012, BMC Cancer.

[27]  Fabrizio Gelain,et al.  3D culture of adult mouse neural stem cells within functionalized self-assembling peptide scaffolds , 2011, International journal of nanomedicine.

[28]  James A Bankson,et al.  Three-dimensional tissue culture based on magnetic cell levitation. , 2010, Nature nanotechnology.

[29]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[30]  Hein Putter,et al.  Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients , 2011, Breast Cancer Research and Treatment.

[31]  C. Lehr,et al.  A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. , 2010, Molecular pharmaceutics.

[32]  Shufang Zhang,et al.  Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. , 2010, Biomaterials.

[33]  I. Tannock,et al.  Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.

[34]  R. Jain,et al.  Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.

[35]  Ana M Soto,et al.  A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. , 2008, Tissue engineering. Part C, Methods.